The Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients

To Examine the Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients as Secondary Treatment

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03601260

Enrollment

700

Registered

2018-07-26

Start date

2018-08-31

Completion date

2018-12-31

Last updated

2018-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Brief summary

The aim of the study is to determine the percentage of cases of acute treatment with Allopurinol in gout patients who have been previously treated.

Interventions

DRUGAllopurinol

Treatment of gout patients by oral dosage of 100 mg-300mg/ day of Allopurinol

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

25 Years to No maximum

Healthy volunteers

Inclusion criteria

* Gout patients

Exclusion criteria

* Pregnant women * Chronic renal failure * Patients with Allopurinal hypersensitivity

Design outcomes

Primary

Measure	Time frame	Description
Gout patients treated with Allopurinol	Six months	Retrospective identification through medical records of percentage of gout patients treated with Allopurinol

Secondary

Measure	Time frame	Description
Patients with contraindication to Allopurinol	Six months	Retrospective identification through medical records of percentage of gout patients with contraindications to Allopurinol

Countries

Israel

Contacts

Primary ContactFadi Khalaila, MD

khalailaf@yahoo.com972-52-3326629

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026